Cargando…

The promise of circulating tumor cell analysis in cancer management

Enumeration and molecular characterization of circulating tumor cells isolated from peripheral blood of patients with cancer can aid selection of targeted therapy for patients, monitoring of response to therapies and optimization of drug development, while also providing valuable information about i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mateo, Joaquin, Gerlinger, Marco, Rodrigues, Daniel Nava, de Bono, Johann S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281949/ https://www.ncbi.nlm.nih.gov/pubmed/25222379 http://dx.doi.org/10.1186/s13059-014-0448-5

Ejemplares similares

Promising Role of Circulating Tumor Cells in the Management of SCLC
por: De Luca, Antonella, et al.
Publicado: (2021)

Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features
por: Perez-Lopez, Raquel, et al.
Publicado: (2018)

Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
por: Lorente, David, et al.
Publicado: (2016)

Circulating Tumor Cells: A Promising Biomarker in the Management of Nasopharyngeal Carcinoma
por: Wu, Jiangtao, et al.
Publicado: (2021)

Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles
por: Nanou, Afroditi, et al.
Publicado: (2018)

The Promise of Circulating Tumor DNA in Head and Neck Cancer
por: Aulakh, Sukhkaran S., et al.
Publicado: (2022)

Circulating Tumor Cells Count and Morphological Features in Breast, Colorectal and Prostate Cancer
por: Ligthart, Sjoerd T., et al.
Publicado: (2013)

Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound
por: Chi, Kim N., et al.
Publicado: (2023)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
por: Nanou, Afroditi, et al.
Publicado: (2018)

Immunovirotherapy for Pediatric Solid Tumors: A Promising Treatment That is Becoming a Reality
por: de la Nava, Daniel, et al.
Publicado: (2022)

Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
por: Salehi, Mahsa, et al.
Publicado: (2023)

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
por: Rescigno, Pasquale, et al.
Publicado: (2018)

Emerging role of circulating tumor cells in cancer management
por: Mego, Michal
Publicado: (2014)

The Potential for Circulating Tumor Cells in Pancreatic Cancer Management
por: Pimienta, Michael, et al.
Publicado: (2017)

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
por: Lozano, Rebeca, et al.
Publicado: (2021)

Circulating endothelial cells in oncology: pitfalls and promises
por: Strijbos, M H, et al.
Publicado: (2008)

Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
por: Zafeiriou, Zafeiris, et al.
Publicado: (2019)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Circulating and Disseminated Tumor Cells in the Management of Advanced Prostate Cancer
por: Kruck, Stephan, et al.
Publicado: (2012)

Clinical Relevance of Circulating Tumor Cells in Prostate Cancer Management
por: Cieślikowski, Wojciech A., et al.
Publicado: (2021)

Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer
por: Zhu, Lei, et al.
Publicado: (2020)

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses
por: Lorente, David, et al.
Publicado: (2016)

Peptide-Functionalized Nanoemulsions as a Promising Tool for Isolation and Ex Vivo Culture of Circulating Tumor Cells
por: Carmona-Ule, Nuria, et al.
Publicado: (2022)

Utilization of Circulating Tumor Cells in the Management of Solid Tumors
por: Kurniali, Peter C., et al.
Publicado: (2023)

Circulating microRNAs: promising breast cancer Biomarkers
por: Heneghan, Helen M, et al.
Publicado: (2011)

Circulating microRNAs as Promising Biomarkers in Colorectal Cancer
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
por: Sun, Wenjie, et al.
Publicado: (2016)

Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine
por: Praharaj, Prakash P., et al.
Publicado: (2018)

Tumor Hypoxia and Circulating Tumor Cells
por: Tinganelli, Walter, et al.
Publicado: (2020)

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes
por: Mezzalira, Silvia, et al.
Publicado: (2019)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
por: Punnoose, Elizabeth A, et al.
Publicado: (2015)

The Position of Circulating Tumor DNA in the Clinical Management of Colorectal Cancer
por: de Abreu, Ana Regina, et al.
Publicado: (2023)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

Circulating Tumor Cells for the Management of Renal Cell Carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer
por: Widschwendter, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a4n0u08hljnmma0re2muvbus0n